Brain metastases: advances over the decades
1Department of Radiation Oncology, University of Toronto, Odette Cancer Centre, 2075 Bayview Ave., Toronto, ON, Canada. may.tsao@sunnybrook.ca.
Annals of Palliative Medicine
|November 7, 2015
Summary
Effective brain metastasis management balances survival and symptom control. Dexamethasone and seizure treatment are key, with surgery or radiosurgery improving outcomes for select patients.
Area of Science:
- Neuro-oncology
- Clinical Neurology
Background:
- Brain metastases present significant morbidity and mortality challenges.
- Effective management requires a focus on both survival and symptom control.
Purpose of the Study:
- To review current management strategies for brain metastases.
- To emphasize symptom management, including quality of life and neurocognition.
Main Methods:
- Systematic literature review.
- Analysis of outcomes including survival, brain control, and symptom management (quality of life, neurological function, neurocognition).
Main Results:
- Dexamethasone manages intracranial edema symptoms; anti-seizure medications are for treatment, not prophylaxis.
- Treatment options range from supportive care to whole brain radiotherapy (WBRT), radiosurgery, or surgery.
- Surgery/radiosurgery offer improved survival for single metastases compared to WBRT alone.
Conclusions:
- Brain metastasis management has evolved, with increasing importance placed on quality of life and neurocognition alongside survival and brain control.
- Future research focuses on advanced radiation techniques, targeted therapies, and neuroprotection.
Related Concept Videos
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression
3.6K
3.6K
Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Metastasis
3.8K
3.8K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K


